Cargando…

Ewing sarcoma of the oral cavity. A review

OBJECTIVES: A review is made of the clinical, diagnostic, therapeutic and survival characteristics of Ewing sarcoma (ES) of the oral cavity. MATERIAL AND METHODS: A systematic literature search was carried out, with restrictions referred to time (1960-2014), language (English and Spanish) and type o...

Descripción completa

Detalles Bibliográficos
Autores principales: Margaix-Muñoz, Maria, Bagán, José, Poveda-Roda, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303334/
https://www.ncbi.nlm.nih.gov/pubmed/28210452
http://dx.doi.org/10.4317/jced.53575
_version_ 1782506693366644736
author Margaix-Muñoz, Maria
Bagán, José
Poveda-Roda, Rafael
author_facet Margaix-Muñoz, Maria
Bagán, José
Poveda-Roda, Rafael
author_sort Margaix-Muñoz, Maria
collection PubMed
description OBJECTIVES: A review is made of the clinical, diagnostic, therapeutic and survival characteristics of Ewing sarcoma (ES) of the oral cavity. MATERIAL AND METHODS: A systematic literature search was carried out, with restrictions referred to time (1960-2014), language (English and Spanish) and type of study (case reports, letters, datasets, reviews). The following MeSH terms and boolean operators were used: Ewing AND Sarcoma AND [tongue, jaw, maxilla, cheek, condyle OR temporomandibular, floor AND mouth, gum OR gingiva, palate OR palatal, lip, uvula, head AND neck]. RESULTS: Seventy-one cases of ES of the oral cavity were documented from 53 articles. The main differences versus ES of other locations were a younger age at manifestation, a shorter time from symptoms onset to diagnosis, and swelling as the most frequent clinical manifestation versus swelling and pain in the rest of disease locations. The way in which ES manifests in the oral cavity is varied and comprises dental displacement (19.7%), dental mobility (7%), root reabsorption (5.6%), destruction of the dental follicle (4.2%), premature exfoliation (4.2%) and paresthesia of the chin (2.8%). Metastatic neck adenopathies appear in 11.3% of the cases. Significant differences in survival are observed between patients with a complete diagnosis of ES (hematoxylin-eosin staining, PAS positivity, CD99 positivity) and those with an incomplete diagnosis. CONCLUSIONS: Ewing sarcoma of the oral cavity presents a series of specific features that distinguish it from ES of other locations. Key words:Primitive neuroectodermal tumor, PNET, Ewing sarcoma, Ewing tumor, sarcoma, oral cavity.
format Online
Article
Text
id pubmed-5303334
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medicina Oral S.L.
record_format MEDLINE/PubMed
spelling pubmed-53033342017-02-16 Ewing sarcoma of the oral cavity. A review Margaix-Muñoz, Maria Bagán, José Poveda-Roda, Rafael J Clin Exp Dent Review OBJECTIVES: A review is made of the clinical, diagnostic, therapeutic and survival characteristics of Ewing sarcoma (ES) of the oral cavity. MATERIAL AND METHODS: A systematic literature search was carried out, with restrictions referred to time (1960-2014), language (English and Spanish) and type of study (case reports, letters, datasets, reviews). The following MeSH terms and boolean operators were used: Ewing AND Sarcoma AND [tongue, jaw, maxilla, cheek, condyle OR temporomandibular, floor AND mouth, gum OR gingiva, palate OR palatal, lip, uvula, head AND neck]. RESULTS: Seventy-one cases of ES of the oral cavity were documented from 53 articles. The main differences versus ES of other locations were a younger age at manifestation, a shorter time from symptoms onset to diagnosis, and swelling as the most frequent clinical manifestation versus swelling and pain in the rest of disease locations. The way in which ES manifests in the oral cavity is varied and comprises dental displacement (19.7%), dental mobility (7%), root reabsorption (5.6%), destruction of the dental follicle (4.2%), premature exfoliation (4.2%) and paresthesia of the chin (2.8%). Metastatic neck adenopathies appear in 11.3% of the cases. Significant differences in survival are observed between patients with a complete diagnosis of ES (hematoxylin-eosin staining, PAS positivity, CD99 positivity) and those with an incomplete diagnosis. CONCLUSIONS: Ewing sarcoma of the oral cavity presents a series of specific features that distinguish it from ES of other locations. Key words:Primitive neuroectodermal tumor, PNET, Ewing sarcoma, Ewing tumor, sarcoma, oral cavity. Medicina Oral S.L. 2017-02-01 /pmc/articles/PMC5303334/ /pubmed/28210452 http://dx.doi.org/10.4317/jced.53575 Text en Copyright: © 2017 Medicina Oral S.L. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Margaix-Muñoz, Maria
Bagán, José
Poveda-Roda, Rafael
Ewing sarcoma of the oral cavity. A review
title Ewing sarcoma of the oral cavity. A review
title_full Ewing sarcoma of the oral cavity. A review
title_fullStr Ewing sarcoma of the oral cavity. A review
title_full_unstemmed Ewing sarcoma of the oral cavity. A review
title_short Ewing sarcoma of the oral cavity. A review
title_sort ewing sarcoma of the oral cavity. a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303334/
https://www.ncbi.nlm.nih.gov/pubmed/28210452
http://dx.doi.org/10.4317/jced.53575
work_keys_str_mv AT margaixmunozmaria ewingsarcomaoftheoralcavityareview
AT baganjose ewingsarcomaoftheoralcavityareview
AT povedarodarafael ewingsarcomaoftheoralcavityareview